| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 8 |
| 1 | ADALIMUMAB | 6 |
| 2 | ETANERCEPT | 4 |
| 3 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 3 |
| 4 | BUPROPION HYDROCHLORIDE | 3 |
| 5 | METHOTREXATE | 3 |
| 6 | METHOTREXATE SODIUM | 3 |
| 7 | NIFEDIPINE | 3 |
| 8 | ONDANSETRON | 3 |
| 9 | ONDANSETRON HYDROCHLORIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OSPEMIFENE | 2 | 0.0008 |
| 1 | ZIPRASIDONE | 2 | 0.0006 |
| 2 | NALOXEGOL OXALATE | 2 | 0.0005 |
| 3 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 2 | 0.0004 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 5 | ETODOLAC | 2 | 0.0003 |
| 6 | BARICITINIB | 1 | 0.0003 |
| 7 | LARONIDASE | 1 | 0.0002 |
| 8 | ELOSULFASE ALFA | 1 | 0.0002 |
| 9 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 6 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Insulin [EPC] | 1 | 0.0000 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 2 | 0.0000 |